首页> Pharmaceutical development and technology> An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine

An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine

导出原文传递

翻译打印收藏纠错

第一作者： Saurabh M. Mishra

作者： Saurabh M. Mishra ^[1] ; Bhagwan D. Rohera

作者单位： College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA ^[1]

关键词 Box-Behnken response surface methodology ODTs optimization QbD quality target product profile risk assessment

发布时间 2020-12-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceutical development and technology

2017年22卷1/8期

889-903页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Pharmaceutical development and technology

2017年22卷1/8期

889-903页

检索历史清除

An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine

Pharmaceutical development and technology

相似文献

同项目论文

Pharmaceutical development and technology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine

Pharmaceutical development and technology

相似文献

同项目论文

Pharmaceutical development and technology

相关期刊

检索历史清除